The COVID-19 pandemic is a catalyst to accelerate the adoption of technology-enabled patient care for epilepsy, according to a new study published in Epilepsia.
Building on the HSE eHealth Ireland funded Epilepsy Lighthouse Project, the research was led by FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, hosted by RCSI University of Medicine and Health Sciences. Funding for the project has continued through the Health Research Board (HRB) Applied Partnership Award.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.